Immunoreactive amino-terminal pro-brain natriuretic peptide (NT-PROBNP): A new marker of cardiac impairment

Clinical Endocrinology

Volumn 47, Issue 3, 1997, Pages 287-296

  Hunt, P J ^a   Richards, A M ^a   Nicholls, M G ^a   Yandle, T G ^a   Doughty, R N ^b   Espiner, E A ^a  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; PRO BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; FUNCTIONAL ASSESSMENT; HEART CATHETERIZATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTENSION; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; PEPTIDE ANALYSIS; PRIORITY JOURNAL;

EID: 0030804506     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.2361058.x     Document Type: Article

References (38)

1. Arakawa, N., Nakamura, M., Aoki, H. & Hiramori, K. (1996) Plasma brain natriuretic peptide concentrations predict survival after acute myocardial infarction. Journal of the American College of Cardiology, 27, 1656-1661.
2. Bonarjee, V.V.S., Omland, T., Nilsen, D.W.T., Caidahl, K., Sunsfjord, J.A. & Dickstein, K. (1995) Plasmaproatrial natriuretic factor(1-98) concentration after myocardial infarction: relation to indices of cardiac and renal function. British Heart Journal, 73, 511-516.
3. Choy, A.J., Darber, D., Lang, C., Pringle, T.H., McNeill, G.P., Kennedy, N.S.J. & Struthers, A.D. (1994) Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods. British Heart Journal, 72, 16-22.
4. Cornbleet, P.J. & Gochman, N. (1979) Incorrect least-squares regression coefficients in method comparison analysis. Clinical Chemistry, 25, 432-438.
5. Crozier, I.G., Ikram, H., Gomez, H.J., Nicholls, M.G., Espiner, E.A. & Warner, N.J. (1986) Haemodynamic effects of atrial peptide infusion in heart failure. Lancet, ii, 1242-1245.
6. Davidson, N.C., Naas, A.A., Hanson, J.K., Kennedy, N.S.J., Coutie, W.J. & Struthers, A.D. (1996) Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction. American Journal of Cardiology, 77, 828-831.
7. Davis, M., Espiner, E., Richards, G., Billings, J., Town, I., Neill, A., Drennan, C., Richards, M., Turner, J. & Yandle, T. (1994) Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet, 343, 440-444.
8. Florkowski, C.M., Richards, A.M., Espiner, E.A., Yandle, T.G. & Frampton, C. (1994) Renal, endocrine, and hemodynamic interactions atrial and brain natriuretic peptides in normal man. American Journal of Physiology, 266, R1244-1250.
9. Hall, C., Cannon, C.P., Forman, S. & Braunwald, E. (1995) Prognostic value of N-terminal proatrial natriuretic factor plasma levels measured within the first 12 hours after myocardial infarction. Journal of the American College of Cardiology, 26, 1452-1456.
10. Hall, C., Rouleau, J.L., Moyè, L., de Champlain, J., Bichet, D., Klein, M., Sussex, B., Packer, M., Rouleau, J., Arnold, M.O., Lamas, G.A., Sestier, F., Gottlieb, S.S., Wun, C.C. & Pfeffer, M.A. (1994) N-terminal proatrial natriuretic factor. An independent predictor of long term prognosis after myocardial infarction. Circulation, 89, 1934-1942.
11. Hall, C., Kjekshus, J., Eneroth, P. & Snapinn, S. (1994) The plasma concentration of N-terminal proatrial natriuretic factor ANF(1-98) is related to prognosis in severe heart failure. Clinical Cardiology, 17, 191-195.
12. Hino, J., Tateyama, H., Minamino, N., Kangawa, K. & Matsuo, H. (1990) Isolation and identification of human brain natriuretic peptides in cardiac atrium. Biochemical and Biophysical Research Communications, 167, 693-700.
13. Holmes, S.J., Espiner, E.A., Richards, A.M., Yandle, T.G. & Frampton, C. (1993) Renal, endocrine, and hemodynamic effects of human brain natriuretic peptide in normal man. Journal of Clinical Endocrinology and Metabolism, 76, 91-96.
14. Hosoda, K., Nakao, K., Mukoyama, M., Saito, Y., Jougasaki, M., Shirakami, G., Suga, S., Ogawa, Y., Yasue, H. & Imura, H. (1991) Expression of brain natriuretic peptide gene in human heart. Production in the ventricle. Hypertension, 17, 1152-1156.
15. Hunt, P.H., Yandle, T.G., Nicholls, M.G., Richards, A.M. & Espiner, E.A. (1995) The amino-terminal portion of probrain natriuretic peptide (proBNP) circulates in human plasma. Biochemical and Biophysical Research Communications, 214, 1175-1183.
16. Kambayashi, Y., Nakao, K., Mukoyama, M., Saito, Y., Ogawa, Y., Shiono, S., Inouye, K., Yoshida, N. & Imura, H. (1990) Isolation and sequence determination of human brain natriuretic peptide in human atrium. FEBS Letters, 259, 341-345.
17. Kettunen, R.V.J., Leppaluoto, J., Jounela, A. & Vuolteenaho, O. (1994) Plasma N-terminal atrial natriuretic peptide in acute myocardial infarction. American Heart Journal, 127, 1449-155.
18. Kohno, M., Horio, T., Yokokawa, K., Yasunari, K., Ikeda, M., Minami, M., Kurihara, N. & Takeda, T. (1995) Brain natriuretic peptide as a marker for hypertensive left ventricular hypertrophy: changes during 1-year antihypertensive therapy with angiotensin-converting enzyme inhibitor. American Journal of Medicine, 98, 257-265.
19. Lerman, A., Gibbons, R.J., Rodeheffer, R.J., Bailey, K.R., McKinley, L.J., Heublein, D.M. & Burnett, J.C. (1993) Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet, 341, 1105-1109.
20. Maack, T. ( 1992) Receptor of atrial natriuretic factor. Annual Review of Physiology, 54, 11-27.
21. Monta, E., Yasue, H., Yoshimura, M., Ogawa, H., Jougasaki, M., Matsumura, T., Mukoyama, M. & Nakao, K. (1993) Increased Plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation, 88, 82-91.
22. Motwani, J.G., McAlpine, H., Kennedy, N. & Struthers, A.D. (1993) Plasma brain natriuretic peptide as in indicator for angiotensin-converting-enzyme inhibition after myocardial infarction. Lancet, 341, 1109-1113.
23. Mukoyama, M., Nakao, K., Hosoda, K., Suga, S., Saito, Y., Ogawa, Y., Shirakami, G., Jougasaki, M., Obata, K., Yasue, H., Kambayashi, Y., Inoye, K. & Imura, H. (1991a) Brain natriuretic peptide as a novel cardiac hormone in humans. Journal of Clinical Investigation, 87, 1402-1412.
24. Mukoyama, M., Nakao, K., Obata, K., Jougasaki, M., Yoshimura, M., Morita, E., Hosoda, K., Suga, S., Ogawa, Y., Yasue, H. & Imura, H. (1991b) Augmented secretion of brain natriuretic peptide in acute myocardial infarction. Biochemical and Biophysical Research Communications, 180, 431-436.
25. Murthy, K.K., Thibault, G. & Cantin, M. (1988) Contribution of blood and systemic circulation to the processing of pro-(atrial natriuretic factor). Biochemical Journal, 250, 665-670.
26. Omland, T., Aakvaag, A., Bonarjee, V.V.S., Caidahl, K., Lie, R.T. & Nilsen, D.W.T. (1996) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Circulation, 93, 1963-1969.
27. Richards, A.M., Crozier, I.G., Yandle, T.G., Espiner, E.A., Ikram, H. & Nicholls, M.G. (1993) Brain natriuretic factor: regional plasma concentrations and correlations with haemodynamic state in cardiac disease. British Heart Journal, 69, 414-417.
28. Sudoh, T., Kangawa, K., Minamino, N. & Matsuo, H. (1988) A new natriuretic peptide in porcine brain. Nature, 332, 78-81.
29. Sundsfjord, J.A., Thibault, G., Larochelle, P. & Cantin, M. (1988) Identification and plasma concentrations of the N-terminal fragment of proatrail natriuretic factor in man. Journal of Clinical Endocrinology and Metabolism, 66, 605-610.
30. Tateyama, H., Hino, J., Minamino, N., Kangawa, K., Minamino, T., Sakai, K., Ogihara, T. & Matsuo, H. (1992) Concentrations and molecular forms of human brain natriuretic peptide in plasma. Biochemical and Biophysical Research Communications, 185, 706-767.
31. Thibault, G., Murthy, K., Gutkowaka, J., Seidah, N.G., Lazure, C., Chrétien, M. & Cantin, M. (1988) NH2-terminal fragment of rat pro-atrial natriuretic factor in the circulation: identification, radioimmunoassay and half-life. Peptides, 9, 47-53.
32. Togashi, K., Kameya, T., Ando, K., Marumo, F. & Kawakami, M. (1991) Brain natriuretic peptides in human plasma, spinal cord and cerebrospinal fluid. Clinica Chimica Acta, 201, 193-200.
33. White, H.D., Norris, R.M., Brown, M.A., Brandt, P.W.T., Whitlock, R.M.L. & Wild, C.J. (1987) Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. Circulation, 76, 44-52.
34. Woods, R.L. (1988) Contribution of the kidney to metabolic clearance of atrial natriuretic peptide. American Journal of Physiology, 255, E934-941.
35. Yandle, T.G., Richards, A.M., Gilbert, A., Fisher, S., Holmes, S. & Espiner, E.A. (1993) Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure. Journal of Clinical Endocrinology and Metabolism, 76, 832-838.
36. Yandle, T.G., Espiner, E.A., Nicholls, M.G. & Duff, H. (1986) Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. Journal of Clinical Endocrinology and Metabolism, 63, 72-79.
37. Yandle, T.G., Veseley, D.V., Hunt, P.J., Espiner, E.A., Richards, A.M., Nicholls, M.G. & Sage, M. (1996) Intracardiac forms of BNP in humans: evidence for amino terminal BNP formation from proBNP prior to secretion. Abstract, Tenth International Congress of Endocrinology, P1, 757.
38. Yasue, H., Yoshimura, M., Sumida, H., Kikuta, K., Kugiyama, K., Jougasaki, M., Ogawa, H., Okumura, K., Mukoyama, M. & Nakao, K. (1994) Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation, 90, 195-203.